{"id":88431,"date":"2025-09-27T07:58:18","date_gmt":"2025-09-27T07:58:18","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/88431\/"},"modified":"2025-09-27T07:58:18","modified_gmt":"2025-09-27T07:58:18","slug":"britain-says-pushing-for-better-outcome-on-us-pharma-tariffs","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/88431\/","title":{"rendered":"Britain says pushing for better outcome on US pharma tariffs"},"content":{"rendered":"\n<p class=\"yf-1090901\">LONDON (Reuters) -Britain on Friday said it was pressing the United States on pharmaceutical <a href=\"https:\/\/finance.yahoo.com\/news\/live\/trump-tariffs-live-updates-trump-vows-export-curbs-india-hike-on-deck-china-and-canada-envoys-visit-us-200619355.html\" data-ylk=\"slk:tariffs;elm:context_link;itc:0;sec:content-canvas;outcm:mb_qualified_link;_E:mb_qualified_link;ct:story;\" class=\"link  yahoo-link\" rel=\"nofollow noopener\" target=\"_blank\">tariffs<\/a> in hope of a beneficial outcome, after <a href=\"https:\/\/www.yahoo.com\/people\/donald-trump\/\" data-ylk=\"slk:President Donald Trump;elm:context_link;itc:0;sec:content-canvas\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">President Donald Trump<\/a> said a new 100% tariff would apply to firms unless they build a manufacturing presence in the country.<\/p>\n<p class=\"yf-1090901\">Trump said the tariffs would apply to any branded or patented pharmaceutical product from October 1 unless the company had already broken ground on building a manufacturing plant in the United States. He did not mention whether they would stack on top of existing national tariffs.<\/p>\n<p class=\"yf-1090901\">&#8220;We know this will be concerning for industry, which is why we&#8217;ve been actively engaging with the U.S. and will continue to do so over the coming days,&#8221; a British government spokesperson said.<\/p>\n<p class=\"yf-1090901\">&#8220;Sectors such as pharmaceuticals are critical to our economy &#8230; so we will continue to press the U.S. for outcomes that reflect the strength of our relationship and deliver real benefits for UK industry.&#8221;<\/p>\n<p class=\"yf-1090901\">Britain in May secured the first tariff deal with Trump, although it has only been partially implemented.<\/p>\n<p class=\"yf-1090901\">Under the agreement, the countries said they intended to negotiate &#8220;significantly preferential treatment outcomes on pharmaceuticals&#8221;. Britain also pledged it would try to improve the &#8220;overall environment&#8221; for pharma firms.<\/p>\n<p class=\"yf-1090901\">Trump has pressured Europe to pay more for U.S. drugs, and major pharma companies have halted investments in Britain, citing a difficult operating environment.<\/p>\n<p class=\"yf-1090901\">Britain&#8217;s science minister Patrick Vallance has acknowledged that the country&#8217;s National Health Service needs to reverse a trend of declining spending on medicines.<\/p>\n<p class=\"yf-1090901\">Major British drugmakers like AstraZeneca and GlaxoSmithKline have manufacturing facilities in the United States and have announced further investments.<\/p>\n<p class=\"yf-1090901\">(Reporting by Alistair Smout; editing by William James, Aidan Lewis)<\/p>\n","protected":false},"excerpt":{"rendered":"LONDON (Reuters) -Britain on Friday said it was pressing the United States on pharmaceutical tariffs in hope of&hellip;\n","protected":false},"author":2,"featured_media":88432,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[174],"tags":[3248,79,179,18,19,17,57975,57974,10595,384],"class_list":{"0":"post-88431","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-economy","8":"tag-britain","9":"tag-business","10":"tag-economy","11":"tag-eire","12":"tag-ie","13":"tag-ireland","14":"tag-pharma-firms","15":"tag-pharmaceutical-product","16":"tag-president-donald-trump","17":"tag-united-states"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/88431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=88431"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/88431\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/88432"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=88431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=88431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=88431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}